EuroIntervention
@eurointervention
Your reference journal for coronary, valvular & structural interventions; and the official journal of PCR and #EuroPCR. IF 9,5. 16/230 of cardiology journals www.eurointervention.pcronline.com
The prospective, multicentre, randomised Icare trial showed that IVL was non-inferior to RA for post-PCI minimal stent area, with less major stent malapposition and similar 12-month clinical outcomes. eurointervention.pcronline.com/article/intr... #cardiosky
Not all calcified nodules behave alike. CCTA-, OCT- and CFD-based modelling revealed greater flow disturbances and shear heterogeneity in eruptive than non-eruptive lesions. #PCI #OCT #cardioed #cardiosky eurointervention.pcronline.com/article/wall...
NEW ISSUE NOW ONLINE. 🔥 - Intravascular lithotripsy versus rotational atherectomy, - OCT insights into side branch DCB treatment, - Haemorrhagic myocardial infarction, - Wall shear stress in calcified nodules, and more. Read it here: eurointervention.pcronline.com/issue/volume...
In the NL-CFT registry, invasive coronary function testing identified vasomotor dysfunction in 4 out of 5 patients, with epicardial spasm occurring more frequently after prior PCI. Read more here👇 eurointervention.pcronline.com/article/prev.... #cardiosky
In the multicentre TRI-NOCA registry, invasive coronary endotyping was associated with tailored pharmacological treatment and improved angina-related quality of life in most endotypes, supporting a more personalised approach to care. #cardiosky eurointervention.pcronline.com/article/endo...
Ticagrelor monotherapy initiated immediately after primary #PCI for #STEMI was associated with similar 1-year ischaemic outcomes and fewer non-access site bleeding events than #DAPT in the pilot STOP-IMH randomised trial. eurointervention.pcronline.com/article/tica... #cardiosky
New issue now online! ✅P2Y12 inhibitor monotherapy after complex PCI; ✅Ticagrelor monotherapy in STEMI; ✅Endotype-based treatment in ANOCA; ✅Vasomotor dysfunction after PCI; ✅Collapse of a new-generation magnesium scaffold; and more eurointervention.pcronline.com/issue/volume... #cardiosky
A single-session transfemoral TAVI and transfemoral/transseptal TMVR using dedicated devices was successfully performed in a patient with complex multivalvular disease. Discover more here: eurointervention.pcronline.com/article/conc... #cardiosky
In the PORTICO IDE trial, the intra-annular Portico valve achieved haemodynamic performance comparable to supra-annular self-expanding valves and lower prosthesis-patient mismatch than SAPIEN 3. eurointervention.pcronline.com/article/pros... #cardioed #cardiosky
In the SAFE-PROTECT randomized trial, the novel AnchorMan device was non-inferior to Watchman 2.5 for 12-month clinical success after LAA closure, while providing improved sealing performance with fewer clinically relevant peridevice leaks. #cardiosky eurointervention.pcronline.com/article/left...
New-generation intra-annular and supra-annular self-expanding TAVI valves showed comparable 1-year clinical and haemodynamic outcomes in the HERA-TAVI registry, highlighting the importance of patient-tailored valve selection. eurointervention.pcronline.com/article/clin... #cardiosky #cardioed
NEW ISSUE ONLINE NOW. ✅AnchorMan vs Watchman for LAA closure, ✅Self-expanding TAVI valves, ✅Prosthesis-patient mismatch, ✅VARC-HBR validation, ✅Percutaneous aspiration for infective endocarditis, ✅Concomitant TAVI-TMVR, 🔗https://eurointervention.pcronline.com/issue/volume-22/number-13
Early haemodynamic valve deterioration after TAVI was associated with stroke, bioprosthetic valve dysfunction, and valve failure in this international multicentre registry. #TAVI #StructuralHeart#TAVI eurointervention.pcronline.com/article/prog...
The PRIME-MR registry demonstrates progressive improvements in mitral TEER outcomes for primary MR, including procedural safety, residual MR, and 1-year durability. #CARDIOSKY eurointervention.pcronline.com/article/temp...
Can intraprocedural haemodynamics improve risk stratification after M-TEER? Read our article here: eurointervention.pcronline.com/article/outc...
First-in-human transcatheter papillary muscle approximation using the VSling system successfully reshaped left ventricular geometry in advanced ischaemic heart failure. #cardiosky eurointervention.pcronline.com/article/tran...
📢 The 2025 Impact Factor is here! EuroIntervention reaches an Impact Factor of 9.2, ranking #21/237 cardiology journals and remaining in the top quartile. Many thanks to our authors, reviewers, editorial board members and readers for their continued support. #CardioEd @pcronline.bsky.social
How should antithrombotic therapy be tailored after ACS-PCI? This review offers practical, evidence-based guidance on balancing bleeding and ischaemic risks to optimize outcome. #cardiosky 🔗 eurointervention.pcronline.com/article/anti...
In STEMI-related cardiogenic shock, earlier ventricular unloading with a microaxial flow pump was associated with lower in-hospital mortality, highlighting door-to-unload time as a potential target for improving outcomes. #cardiosky eurointervention.pcronline.com/article/door...
The latest issue now online: - ESC Clinical Consensus Statement on DAPT after ACS, - Door-to-unload time in STEMI-CS, - M-TEER and left atrial pressure, - Temporal trends in mitral intervention, - Transcatheter papillary muscle banding, and more. eurointervention.pcronline.com/issue/volume...
From ISAR-REACT 5 to contemporary DAPT and monotherapy approaches, this Debate examines why the optimal P2Y12 inhibitor in ACS remains an unresolved question. #cardiosky Read more here: eurointervention.pcronline.com/article/pras...
First-in-human experience with the Unica cross-caval device for severe tricuspid regurgitation. Among high-risk patients, implantation was associated with high procedural success, haemodynamic improvement and encouraging early clinical outcomes. eurointervention.pcronline.com/article/firs...
From CAD assessment to coronary reaccess, this State-of-the-Art review provides practical guidance on coronary interventions throughout the TAVI journey. #cardiosky eurointervention.pcronline.com/article/tavi... #TAVI #CoronaryInterventions #StructuralHeartDisease
What should really guide PCI decision-making? And why do authors, reviewers, editors and readers often see the same paper differently? Two discussions explored at #EuroPCR through EuroIntervention’s collaboration sessions with @thelancet.com and @jaccjournals.bsky.social. 👉 Swipe for highlights
A comprehensive overview by Craig et al. of current evidence regarding the timing of TAVI in aortic stenosis, including recent randomised data and future directions for personalised decision-making in asymptomatic and moderate disease. #EuroPCR eurointervention.pcronline.com/article/timi...
DCB use in de novo PCI is expanding, but optimal guidance remains unclear. This viewpoint discusses the potential role of intracoronary imaging to guide lesion selection, preparation, and optimisation—highlighting key evidence gaps. #CARDIOSKY eurointervention.pcronline.com/article/intr...
The “no-reflow” phenomenon in STEMI reflects persistent microvascular dysfunction despite restored coronary patency. This review provides a comprehensive overview of its multifactorial pathophysiology and current therapeutic strategies. #cardiosky eurointervention.pcronline.com/article/slow...
In patients with AF and stable CAD, impaired renal function is associated with higher ischemic and bleeding risk. Edoxaban monotherapy reduces net adverse clinical events compared with dual therapy, irrespective of renal function. #cardiosky eurointervention.pcronline.com/article/impa...
Deeper LAAC implantation is associated with adverse flow profiles and higher device-related thrombus risk, highlighting the importance of implantation depth in procedural optimisation. #Cardiology #LAAC #cardiosky eurointervention.pcronline.com/article/impa...